Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth Driver: A Major Catalyst in the Evolution of the Flow Cytometry In Oncology And Immunology Market in 2025

What market dynamics are playing a key role in accelerating the growth of the flow cytometry in oncology and immunology market?
The escalating incidence of cancer is predicted to stimulate the advancement of flow cytometry in the oncology and immunology sector. Cancer, a term encapsulating a range of conditions characterized by unchecked proliferation and dispersion of abnormal body cells, is a key area of application for flow cytometry, particularly within oncology and immunology studies examining cancer and immune cells. For instance, in October 2022, Macmillan Cancer Support, a health charity based in the UK, reported that 3 million individuals were affected by cancer in 2020, with projections suggesting an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As such, the surge in cancer incidence is instrumental in fueling the growth of flow cytometry in the oncology and immunology markets.

Get Your Flow Cytometry In Oncology And Immunology Market Report Here:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

How will the growth rate of the flow cytometry in oncology and immunology market shape industry trends by 2034?
The market size for flow cytometry in oncology and immunology has experienced swift growth in the past few years. Forecasts anticipate a jump from $2.11 billion in 2024 to $2.33 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. The growth during the historical period is linked to progress in cancer research, an expansion in immunology research, advances in diagnostic applications, an increase in autoimmune diseases, along with developments in drugs and clinical trials.

In the forthcoming years, the market size for flow cytometry in oncology and immunology is predicted to experience substantial growth. The market is projected to expand to $3.46 billion by 2029, with a compound annual growth rate (CAGR) of 10.4%. Factors resulting in this growth during the forecast period include integration with genomics and proteomics, an increase in the usage of single-cell analysis, growing applications in infectious diseases, an increase in cancer cases, and the introduction of point-of-care flow cytometry. Key tendencies in this forecast period encompassing immunophenotyping for immunotherapy, miniaturization of flow cytometry systems, multiparametric analysis, transitioning towards spectral flow cytometry, and cooperative research endeavors.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What trends are poised to drive the future success of the flow cytometry in oncology and immunology market?
Innovations in technology are emerging as a significant trend in the oncology and immunology flow cytometry market. To maintain their market foothold, leading companies active in this sector are embracing these new technologies. For example, Becton Dickinson, a medical technology firm based in the US, introduced the BD Research Cloud for oncology and immunology flow cytometry in September 2022. The BD Cloud, a cloud-based software system, simplifies the flow cytometry process for research professionals working in fields like immunology, virology, infectious disease, and oncology surveillance, promoting more efficient and high-quality studies. Becton Dickinson is utilizing cutting-edge technologies, including the BD Horizon RealYellow and RealBlue Reagents and the newly launched BD FACSDiscover S8 Cell Sorter equipped with BD CellView Image Technology. These tools enhance flow cytometry capabilities and provide researchers with the resources necessary to further their significant studies. Designed on a standard cloud infrastructure, the BD Research Cloud is especially compatible with BD equipment and reagents.

Which primary segments of the flow cytometry in oncology and immunology market are driving growth and industry transformations?
The flow cytometry in oncology and immunology market covered in this report is segmented -

1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469

Which geographical regions are pioneering growth in the flow cytometry in oncology and immunology market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the flow cytometry in oncology and immunology market landscape?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Is Covered In The Flow Cytometry In Oncology And Immunology Global Market Report?

• Market Size Forecast: Examine the flow cytometry in oncology and immunology market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the flow cytometry in oncology and immunology market for a structured understanding.
• Key Players Overview: Analyze major players in the flow cytometry in oncology and immunology market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the flow cytometry in oncology and immunology market.
• Segment Contributions: Evaluate how different segments drive overall growth in the flow cytometry in oncology and immunology market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the flow cytometry in oncology and immunology market.
• Industry Challenges: Identify potential risks and obstacles affecting the flow cytometry in oncology and immunology market.
• Competitive Landscape: Review strategic developments in the flow cytometry in oncology and immunology market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.